Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact

	Gene summary
	Malignant transformation analysis
	Malignant transformation related pathway analysis
	Cell-cell communication analysis
	Single-cell gene regulatory network inference analysis
	Somatic mutation of malignant transformation related genes
	Related drugs of malignant transformation related genes

Gene: MKKS

Gene summary for MKKS

Gene summary.

Gene information	Species	Human
	Gene symbol	MKKS
	Gene ID	8195
	Gene name	MKKS centrosomal shuttling protein
	Gene Alias	BBS6
	Cytomap	20p12.2
	Gene Type	protein-coding
	GO ID	GO:0000003
	UniProtAcc	B7Z3W9

Top

Malignant transformation analysis

Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells

Malignant transformation involving gene list.

Entrez ID	Symbol	Replicates	Species	Organ	Tissue	Adj P-value	Log2FC	Malignancy
8195	MKKS	HTA11_1938_2000001011	Human	Colorectum	AD	2.33e-08	3.93e-01	-0.0811
8195	MKKS	HTA11_78_2000001011	Human	Colorectum	AD	7.66e-04	2.72e-01	-0.1088
8195	MKKS	HTA11_347_2000001011	Human	Colorectum	AD	2.29e-25	5.88e-01	-0.1954
8195	MKKS	HTA11_1391_2000001011	Human	Colorectum	AD	3.51e-11	4.02e-01	-0.059
8195	MKKS	HTA11_866_3004761011	Human	Colorectum	AD	6.27e-06	2.69e-01	0.096
8195	MKKS	HTA11_7663_2000001011	Human	Colorectum	SER	2.57e-02	4.12e-01	0.0131
8195	MKKS	HTA11_10623_2000001011	Human	Colorectum	AD	2.78e-02	3.17e-01	-0.0177
8195	MKKS	HTA11_99999970781_79442	Human	Colorectum	MSS	1.35e-05	2.91e-01	0.294
8195	MKKS	HTA11_99999965104_69814	Human	Colorectum	MSS	1.29e-08	5.28e-01	0.281
8195	MKKS	HTA11_99999971662_82457	Human	Colorectum	MSS	2.11e-03	2.69e-01	0.3859
8195	MKKS	A015-C-203	Human	Colorectum	FAP	3.61e-02	-8.65e-02	-0.1294
8195	MKKS	LZE2T	Human	Esophagus	ESCC	1.25e-05	1.33e+00	0.082
8195	MKKS	LZE4T	Human	Esophagus	ESCC	1.00e-14	6.27e-01	0.0811
8195	MKKS	LZE7T	Human	Esophagus	ESCC	4.31e-04	5.09e-01	0.0667
8195	MKKS	LZE8T	Human	Esophagus	ESCC	7.11e-05	2.70e-01	0.067
8195	MKKS	LZE22D1	Human	Esophagus	HGIN	3.13e-02	7.35e-02	0.0595
8195	MKKS	LZE24T	Human	Esophagus	ESCC	2.44e-06	3.54e-01	0.0596
8195	MKKS	LZE6T	Human	Esophagus	ESCC	6.87e-10	7.70e-01	0.0845
8195	MKKS	P1T-E	Human	Esophagus	ESCC	2.21e-10	8.14e-01	0.0875
8195	MKKS	P2T-E	Human	Esophagus	ESCC	1.43e-32	6.97e-01	0.1177

Page: 1 2 3 4 5 6 7

Transcriptomic changes along malignancy continuum.

Tissue	Expression Dynamics	Abbreviation
Colorectum (GSE201348)		FAP: Familial adenomatous polyposis
		CRC: Colorectal cancer
Colorectum (HTA11)		AD: Adenomas
		SER: Sessile serrated lesions
		MSI-H: Microsatellite-high colorectal cancer
		MSS: Microsatellite stable colorectal cancer
Esophagus		ESCC: Esophageal squamous cell carcinoma
		HGIN: High-grade intraepithelial neoplasias
		LGIN: Low-grade intraepithelial neoplasias
Liver		HCC: Hepatocellular carcinoma
		NAFLD: Non-alcoholic fatty liver disease
Oral Cavity		EOLP: Erosive Oral lichen planus
		LP: leukoplakia
		NEOLP: Non-erosive oral lichen planus
		OSCC: Oral squamous cell carcinoma
Prostate		BPH: Benign Prostatic Hyperplasia
Skin		AK: Actinic keratosis
		cSCC: Cutaneous squamous cell carcinoma
		SCCIS:squamous cell carcinoma in situ

∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer

Figure of enriched GO biological processes.

Tissue	Disease Stage	Enriched GO biological Processes
Colorectum	AD
Colorectum	SER
Colorectum	MSS
Colorectum	MSI-H
Colorectum	FAP

∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).

Page: 1 2 3 4 5 6 7 8 9

Enriched GO biological processes.

GO ID	Tissue	Disease Stage	Description	Gene Ratio	Bg Ratio	pvalue	p.adjust	Count
GO:00073691	Colorectum	SER	gastrulation	43/2897	185/18723	3.44e-03	2.92e-02	43
GO:00310321	Colorectum	SER	actomyosin structure organization	45/2897	196/18723	3.60e-03	3.03e-02	45
GO:00614581	Colorectum	SER	reproductive system development	87/2897	427/18723	3.69e-03	3.07e-02	87
GO:0045444	Colorectum	SER	fat cell differentiation	51/2897	229/18723	3.96e-03	3.26e-02	51
GO:01100201	Colorectum	SER	regulation of actomyosin structure organization	26/2897	100/18723	4.43e-03	3.54e-02	26
GO:00459271	Colorectum	SER	positive regulation of growth	56/2897	259/18723	5.10e-03	3.91e-02	56
GO:00486081	Colorectum	SER	reproductive structure development	85/2897	424/18723	6.33e-03	4.56e-02	85
GO:00070152	Colorectum	MSS	actin filament organization	146/3467	442/18723	1.16e-13	2.67e-11	146
GO:00325352	Colorectum	MSS	regulation of cellular component size	127/3467	383/18723	3.44e-12	5.79e-10	127
GO:00329702	Colorectum	MSS	regulation of actin filament-based process	128/3467	397/18723	2.47e-11	3.49e-09	128
GO:19029032	Colorectum	MSS	regulation of supramolecular fiber organization	121/3467	383/18723	3.63e-10	3.28e-08	121
GO:00322712	Colorectum	MSS	regulation of protein polymerization	83/3467	233/18723	3.99e-10	3.49e-08	83
GO:00081542	Colorectum	MSS	actin polymerization or depolymerization	79/3467	218/18723	4.14e-10	3.49e-08	79
GO:00300412	Colorectum	MSS	actin filament polymerization	71/3467	191/18723	8.77e-10	6.92e-08	71
GO:00080642	Colorectum	MSS	regulation of actin polymerization or depolymerization	70/3467	188/18723	1.06e-09	8.25e-08	70
GO:00308322	Colorectum	MSS	regulation of actin filament length	70/3467	189/18723	1.38e-09	1.03e-07	70
GO:00432542	Colorectum	MSS	regulation of protein-containing complex assembly	130/3467	428/18723	1.38e-09	1.03e-07	130
GO:00329562	Colorectum	MSS	regulation of actin cytoskeleton organization	113/3467	358/18723	1.46e-09	1.07e-07	113
GO:00308332	Colorectum	MSS	regulation of actin filament polymerization	65/3467	172/18723	2.05e-09	1.45e-07	65
GO:00512582	Colorectum	MSS	protein polymerization	97/3467	297/18723	2.98e-09	2.07e-07	97

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Enriched KEGG pathways.

Pathway ID

Tissue

Disease Stage

Description

Gene Ratio

Bg Ratio

pvalue

p.adjust

qvalue

Count

Page: 1

Top

Cell-cell communication analysis

Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states

Ligand

Receptor

LRpair

Pathway

Tissue

Disease Stage

Page: 1

Top

Single-cell gene regulatory network inference analysis

Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states

Cell Type

Tissue

Disease Stage

Target Gene

RSS

Regulon Activity

∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.

Page: 1

Top

Somatic mutation of malignant transformation related genes

Annotation of somatic variants for genes involved in malignant transformation

Hugo Symbol

Variant Class

Variant Classification

dbSNP RS

HGVSc

HGVSp

HGVSp Short

SWISSPROT

BIOTYPE

SIFT

PolyPhen

Tumor Sample Barcode

Tissue

Histology

Sex

Age

Stage

Therapy Types

Drugs

Outcome

MKKS

SNV

Missense_Mutation

c.1133G>T

p.Arg378Ile

p.R378I

Q9NPJ1

protein_coding

deleterious(0)

possibly_damaging(0.902)

TCGA-AC-A23H-01

Breast

breast invasive carcinoma

Female

>=65

I/II

Unknown

MKKS

SNV

Missense_Mutation

c.1045G>T

p.Asp349Tyr

p.D349Y

Q9NPJ1

protein_coding

deleterious(0)

probably_damaging(0.948)

TCGA-AC-A23H-01

Breast

breast invasive carcinoma

Female

>=65

I/II

Unknown

MKKS

SNV

Missense_Mutation

novel

c.503G>A

p.Arg168Lys

p.R168K

Q9NPJ1

protein_coding

tolerated(0.89)

benign(0.001)

TCGA-AC-A5XS-01

Breast

breast invasive carcinoma

Female

>=65

I/II

Hormone Therapy

femara

MKKS

SNV

Missense_Mutation

novel

c.8N>A

p.Arg3His

p.R3H

Q9NPJ1

protein_coding

deleterious(0.02)

probably_damaging(0.964)

TCGA-AO-A03L-01

Breast

breast invasive carcinoma

Female

<65

III/IV

Chemotherapy

cyclophosphamide

MKKS

SNV

Missense_Mutation

novel

c.1615N>A

p.Leu539Met

p.L539M

Q9NPJ1

protein_coding

deleterious(0)

probably_damaging(0.934)

TCGA-LL-A441-01

Breast

breast invasive carcinoma

Female

<65

I/II

Chemotherapy

taxotere

MKKS

insertion

In_Frame_Ins

novel

c.22_23insTCAACTGCCCTCAAGGTGGCACTCTTTTGTACAACTTTATCC

p.Lys8delinsIleAsnCysProGlnGlyGlyThrLeuLeuTyrAsnPheIleGln

p.K8delinsINCPQGGTLLYNFIQ

Q9NPJ1

protein_coding

TCGA-B6-A0I5-01

Breast

breast invasive carcinoma

Female

<65

I/II

Unknown

MKKS

SNV

Missense_Mutation

novel

c.1166N>T

p.Thr389Met

p.T389M

Q9NPJ1

protein_coding

deleterious(0.01)

possibly_damaging(0.88)

TCGA-2W-A8YY-01

Cervix

cervical & endocervical cancer

Female

<65

I/II

Chemotherapy

cisplatin

MKKS

SNV

Missense_Mutation

novel

c.173N>T

p.Ser58Leu

p.S58L

Q9NPJ1

protein_coding

deleterious(0)

probably_damaging(0.997)

TCGA-HM-A4S6-01

Cervix

cervical & endocervical cancer

Female

<65

III/IV

Chemotherapy

cisplatin

MKKS

SNV

Missense_Mutation

c.631G>T

p.Asp211Tyr

p.D211Y

Q9NPJ1

protein_coding

deleterious(0)

probably_damaging(0.98)

TCGA-AA-A010-01

Colorectum

colon adenocarcinoma

Female

<65

I/II

Chemotherapy

folinic

MKKS

SNV

Missense_Mutation

rs750058438

c.235N>A

p.Ala79Thr

p.A79T

Q9NPJ1

protein_coding

tolerated(0.84)

benign(0.01)

TCGA-CA-6717-01

Colorectum

colon adenocarcinoma

Male

<65

I/II

Chemotherapy

oxaliplatin

Page: 1 2 3 4 5

Top

Related drugs of malignant transformation related genes

Identification of chemicals and drugs interact with genes involved in malignant transfromation

(DGIdb 4.0)

Entrez ID

Symbol

Category

Interaction Types

Drug Claim Name

Drug Name

PMIDs

Page: 1